The HERCULES trial shows pembrolizumab plus chemotherapy produces a 39.4% response rate in advanced penile cancer, offering new treatment hope globally.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/hercules-trial-brings-hope-advanced-penile-cancer-2025a1000rzn?src=rss
Author :
Publish date : 2025-10-16 12:28:00
Copyright for syndicated content belongs to the linked Source.
